75000 - Document - Document And Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75080 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Company and Nature of Business
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Balance Sheet Details
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Loans
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Segment and Geographic Information
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Basic and Diluted Net Loss Per Common Share
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Balance Sheet Details (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Loans (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Related Party Transactions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Segment and Geographic Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Basic and Diluted Net Loss Per Common Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Company and Nature of Business - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentage of Revenue and Accounts Receivables from Customers (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentage of Revenue and Accounts Receivables from Customers (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Customer Type (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Customer Type (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Revenue - Schedule of Contract Assets and Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Revenue - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Revenue - Additional Information (Details 1)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Balance Sheet Details - Schedule of Inventory and Other Deferred Costs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Balance Sheet Details - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Balance Sheet Details - Schedule of Accrued and Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Recurring Basis and Level of Inputs used in such Measurements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Fair Value Measurements - Amortized Costs and Fair Value of Marketable Debt Securities by Contractual Maturity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Fair Value Measurements - Schedule of Risk-free Interest Rate Based on U.S. Treasury Yield Curve Over Expected Term of Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Level 3 Financial Instruments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Loans - Schedule of Amounts Outstanding (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Loans - Schedule of Amounts Outstanding (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Loans - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Leases - Components of Lease Costs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Related Party Transactions - Schedule of Amounts of Transactions along with Amount Due From and To Tempus (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Stock-Based Compensation - Summary of Shares of Common Stock Reserved for Issuance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Stock-Based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Stock-Based Compensation - Summary of Weighted-average Assumptions Used in Determination of Fair Value of Service-Based Stock Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Stock-Based Compensation - Summary of Performance Based RSU Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Award Type (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Function (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Segment and Geographic Information - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Segment and Geographic Information - Schedule of net revenues by geographic region (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Segment and Geographic Information - Schedule of reported segment revenue, segment loss, and significant segment expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Basic and Diluted Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Net Loss per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Basic and Diluted Net Loss Per Common Share - Schedule of Potentially Dilutive Shares Excluded from Computation of Diluted Net Loss per Common Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, vested
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Outstanding Options, Weighted-Average Exercise Price, forfeited or expired
Proceeds from sales of property and equipment
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from Sale of Property, Plant, and Equipment, Total
Weighted-average stock price
Weighted Average Stock Price Per Share
Weighted average stock price per share.
Accrued Employee Benefits Current
Employee ESPP contributions
Concentration Risk By Type [Axis]
Concentration Risk Type
Finance Lease, Liability
Finance Lease, Liability, Total
Finance lease ROU liabilities
Entity Incorporation State Country Code
Entity Incorporation, State or Country Code
Preferred Stock Shares Issued
Preferred stock, shares issued
Statement of Financial Position Location, Balance [Domain]
Beginning balance
Ending balance
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Increase Decrease In Accounts Payable
Accounts payable
Increase (Decrease) in Accounts Payable, Total
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Less than 1 year
Long Term Debt Noncurrent
Long-term portion (included in other long-term liabilities)
Long-Term Debt, Excluding Current Maturities, Total
Plan Name [Axis]
Plan Name
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
Unrealized loss position for 12 months or greater on security
Entity Current Reporting Status
Entity Current Reporting Status
Proceeds from Warrant Exercises
Proceeds from exercise of Tempus Warrants
U S Government Agencies Debt Securities [Member]
U.S. Agency Securities
Fair Value Inputs Level2 [Member]
Level 2
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Common Stock Shares Authorized
Common stock, shares authorized
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
Unvested Restricted Stock Units, Aggregate Fair Value
Fair Value by Liability Class [Domain]
Document Fiscal Period Focus
Document Fiscal Period Focus
Finance Lease, Liability, to be Paid
Finance Lease, Liability, to be Paid, Total
Finance lease payments due
Other Noncurrent Liabilities [Member]
Other Long-term Liabilities
Revenue from Contract with Customer [Abstract]
Entity Shell Company
Entity Shell Company
Population Sequencing
Population Sequencing [Member]
Population sequencing.
Short Term Investments [Member]
Short-term Investments
Veterans affairs million veteran program.
Veterans Affairs Million Veteran Program [Member]
VA MVP
Cash And Cash Equivalents At Carrying Value
Cash and cash equivalents
Cash and cash equivalents, Adjusted Cost
Operating Lease, Impairment Loss
Noncash lease impairment expense
Lease impairment
Tranche two.
Tranche Two [Member]
February 2026
Lease expiration month and year
Lease Expiration Month And Year
Lease expiration month and year.
Common Stock Shares Issued
Common stock, shares, issued
Revenue From Contract With Customer [Member]
Revenue
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]
Asset Class
Statement [Table]
Statement [Table]
Right-of-use asset obtained in exchange for operating lease liability
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Weighted-average grant date fair value of options granted
At-the-Market Equity Offerings
At-Market Equity Offerings [Policy Text Block]
At-Market Equity Offerings.
Statement [Line Items]
Statement [Line Items]
Entity Filer Category
Entity Filer Category
Common Stock Value Outstanding
Common stock, $0.0001 par value - 200,000,000 shares authorized; 88,745,366 and 85,171,146 shares issued and outstanding, respectively
Liabilities And Stockholders Equity
Total liabilities and stockholders’ equity
Payables and Accruals [Abstract]
Payables and Accruals [Abstract]
Long Term Debt Current
Less: current portion (included in accrued and other current liabilities)
Long-Term Debt, Current Maturities, Total
Property Plant And Equipment By Type [Axis]
Long-Lived Tangible Asset
Debt Instrument, Frequency of Periodic Payment
Debt instrument, periodic payment
Cash And Cash Equivalents Fair Value Disclosure
Cash and cash equivalents, Fair Value
Noncash or Part Noncash Acquisition, Payables Assumed
Acquisition of property and equipment included in accounts payable and accrued liabilities
Other Noncash Income Expense
Other
Other Noncash Income (Expense), Total
Investment Income Interest
Interest income
Interest income
Warrant Liability
Warrant Liability [Member]
Warrant liability.
Segment Geographical [Domain]
Geographical
Cash and cash equivalents, gross unrealized gains.
Cash And Cash Equivalents Gross Unrealized Gains
Cash and cash equivalents, Unrealized Gains
Additional Paid In Capital Common Stock
Additional paid-in capital
Lessee, Finance Lease, Existence of Option to Terminate [true false]
Finance lease option to terminate [true false]
Related Party [Member]
Related Party
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Measurement Input, Risk Free Interest Rate [Member]
Risk-free Interest Rate
Lab equipment .
Lab Equipment [Member]
Lab Equipment
Vesting [Domain]
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Outstanding Options, Number of Shares, granted
Disaggregation Of Revenue [Table]
Disaggregation Of Revenue [Table]
Schedule of Computation of Basic and Diluted Net Loss per Share
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Richard Chen [Member]
Richard Chen.
Richard Chen
Stephen Moore [Member]
Stephen moore.
Stephen Moore
Earnings Per Share Basic
Net loss per share, basic
Net loss per common share-basic
Earnings Per Share, Basic, Total
Disaggregation Of Revenue Table [Text Block]
Schedule of Revenue Disaggregated by Customer Type
Repayment of loans
Repayments of Long-Term Debt
Repayments of Long-Term Debt, Total
Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold
Payroll and related costs
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
Foreign currency translation adjustment
Net changes in foreign currency translation adjustments
Net changes in foreign currency translation adjustments
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Outstanding Options, Number of Shares, Ending Balance
Outstanding Options, Number of Shares, Beginning Balance
Performance-based stock option activity, number of shares
Percentage Of Its Gross Revenues Attributable To Such License
Percentage of its gross revenues attributable to such license
Percentage of its gross revenues attributable to such license
Liabilities Current
Total current liabilities
Current liabilities
Increase Decrease In Accounts Receivable
Accounts receivable
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of the Changes in the Fair Value of the Companies Level 3 Financial Instruments
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair Value
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Stockholders Equity [Abstract]
Stockholders’ equity
Entity Small Business
Entity Small Business
Percentage of down payment.
Percentage Of Down Payment
Percentage of down payment
Retained Earnings Accumulated Deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Liabilities Current.
Liabilities Current [Member]
Current Liabilities
Preferred Stock Value Outstanding
Preferred stock, $0.0001 par value — 10,000,000 shares authorized; none issued
Warrants and Rights Outstanding, Measurement Input
Warrants measurement input
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Stock-Based Compensation
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Leases [Abstract]
Contract With Customer Liability
Contract liabilities
Total contract liabilities
Total contract liabilities
Total contract liabilities
Lessee Lease Description [Line Items]
Lessee Lease Description [Line Items]
Amendment Flag
Amendment Flag
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrant issued to purchase stock
Liabilities And Stockholders Equity [Abstract]
Liabilities and Stockholders’ Equity
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Lessee, Finance Lease Termination Payment Purchase Price
Lessee, finance lease termination payment purchase price.
Finance lease termination payment purchase price
Net Cash Provided By Used In Operating Activities
Net cash used in operating activities
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock [Member]
Common Stock
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Outstanding Options, Weighted-Average Exercise Price, granted
Lessee Operating Lease Liability Payments Due Year Three
2028
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Accumulated depreciation and amortization
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Entity Address, Address Line One
Entity Address, Address Line One
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Summary of Weighted-average Assumptions Used in Determination of Fair Value of Stock Options
Fair Value By Fair Value Hierarchy Level [Axis]
Fair Value Hierarchy and NAV
Earnings Per Share [Abstract]
Total
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
Aaron Tachibana [Member]
Aaron Tachibana.
Aaron Tachibana
Supplemental Cash Flow Information [Abstract]
Supplemental cash flow information:
Lessee operating lease liability payments due after year four.
Lessee Operating Lease Liability Payments Due After Year Four
2030 and thereafter
Statement of Financial Position Location, Balance [Axis]
Operating Lease Right Of Use Asset
Operating lease right-of-use assets
Payments To Acquire Available For Sale Securities Debt
Purchases of available-for-sale debt securities
Debt Instrument Redemption Period [Axis]
Debt Instrument, Redemption, Period
Class of Warrant or Right [Axis]
Finance lease option to terminate description
Lessee, Finance Lease, Option to Terminate
Document Type
Document Type
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Type Of Arrangement
Equity, Fair Value Disclosure, Total
Equity, Fair Value Disclosure
Total fair value of Tempus Warrants (in thousands)
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
ArrangementsAndNonarrangementTransactionsMember
Entity Central Index Key
Entity Central Index Key
Orders and results delivery fees and net promotional fees.
Orders and Results Delivery Fees and Net Promotional Fees
Orders and results delivery fees and net promotional fees
Increase decrease in operating lease liabilities.
Increase Decrease In Operating Lease Liabilities
Operating lease liabilities
At-the-Market Sales Agreement.
At Market Sales Agreement [Member]
At Market Sales Agreement
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Net change in cash, cash equivalents and restricted cash
Fair Value Adjustment of Warrants
Change in fair value of the Tempus Warrants
Noncash gains for change in fair value of the Tempus Warrants
Noncash losses for change in fair value of the Tempus Warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Potentially dilutive securities excluded from computation of diluted net loss per share
Balance Sheet Related Disclosures [Abstract]
Common Stock Par Or Stated Value Per Share
Common stock, par value
Proceeds from payment agreements with financing entity.
Proceeds From Payment Agreements With Financing Entity
Proceeds from loans
Vesting in March 2027
Share-Based Payment Arrangement, Tranche One [Member]
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Outstanding Options, Weighted-Average Remaining Contractual Term (in years)
Performance-based stock option activity, remaining contractual term
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
Volatility, maximum
Available For Sale Debt Securities Amortized Cost Basis
Investments, Adjusted Cost
Debt securities, aggregate cost basis
Available For Sale Securities Debt Securities
Investments, Fair Value
Debt securities, fair value
Debt Securities, Available-for-Sale, Total
Tempus warrants.
Tempus Warrants [Member]
Tempus Warrants
Stock Issued During Period Shares Stock Options Exercised
Proceeds from exercise of stock options, shares
Outstanding Options, Number of Shares, exercised
Debt Disclosure [Abstract]
Cost Of Sales [Member]
Costs of revenue
Current Fiscal Year End Date
Current Fiscal Year End Date
Reserved for future ESPP
Shares of common stock reserved for future issuance under ESPP.
Shares Of Common Stock Reserved For Future Issuance Under E S P P
Document Quarterly Report
Document Quarterly Report
Entity Address, State or Province
Entity Address, State or Province
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
Ending Balance, Number of Shares
Beginning Balance, Number of Shares
Comprehensive Income Net Of Tax
Comprehensive loss
Investments, Unrealized Gains
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
Common Stock Capital Shares Reserved For Future Issuance
Total common stock reserved for stock awards
Noncash gain related to liability.
Noncash Gain Related To Liability
Noncash gain related to liability classified Tempus Warrants
Two thousand eleven and two thousand nineteen equity incentive plan and two thousand twenty inducement plan.
Two Thousand Eleven And Two Thousand Nineteen Equity Incentive Plan And Two Thousand Twenty Inducement Plan [Member]
2011 Plan, 2019 Plan and Inducement Plan
Class of Warrant or Right [Domain]
Statement Geographical [Axis]
Geographical
Increase (Decrease) in Accounts Receivable, Related Parties
Accounts receivable includes related party
Contract With Customer Liability Revenue Recognized
Contract liability, revenue recognized
Accounts Receivable [Member]
Accounts Receivable
Professional services
Professional Fees
Stock Issued During Period, Value, Stock Options Exercised
Proceeds from exercise of stock options
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
Schedule of revenue disaggregated by customer type
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax
Reclassification of adjustments to net loss due to dissolution of Personalis (Shanghai) Ltd
Reclassification of adjustments to net loss due to dissolution of Personalis (Shanghai) Ltd
Other Assets Noncurrent
Other long-term assets
Fair Value Measurement Inputs and Valuation Techniques [Table]
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Share-based payment award, vesting percentage
Fair value determined at settlement as the fair value of per share
Financial Instrument Subject to Mandatory Redemption, Par Value Per Share
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Grant date fair value
Interest Expense Debt
Interest expense
Interest Expense, Debt, Total
Debt Instrument Unamortized Discount
Less: unamortized discount
Debt Instrument, Unamortized Discount, Total
Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]
Stock Based Compensation Expense by Award Type and Function
Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income (Loss)
Name Of Major Customer [Domain]
Customer
Cash [Member]
Cash
Lessee, Finance Lease, Number of Monthly Installment Payments
Lessee, finance lease, number of monthly installment payments.
Finance lease, number of monthly installment payments
Lessee Operating Lease Option To Extend
Operating lease, option to extend
Selling General And Administrative Expense
Selling, general and administrative
Selling, General and Administrative Expense, Total
Investment Agreement with Merck [Member]
Investment Agreement with Merck.
Investment Agreement with Merck
Minimum [Member]
Minimum
Lessee operating lease liability discount on obligation amount.
Lessee Operating Lease Liability Discount On Obligation Amount
Less: imputed interest
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, granted
Fair value
Financial Instrument [Axis]
Financial Instrument
Assets Current [Abstract]
Current assets
Unvested restricted stock units.
Unvested Restricted Stock Units [Member]
Unvested RSUs
Noncash lease expense.
Noncash Lease Expense
Noncash operating lease cost
Fair Value, Inputs, Level 3 [Member]
Fair Value Inputs Level3
Level 3
Segment Reporting [Abstract]
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]
Schedule of Financial Assets Measured at Fair Value on Recurring Basis and Level of Inputs used in such Measurements
Liabilities Current [Abstract]
Current liabilities
Loans Payable Current
Loans—current portion (Note 6)
Loans Payable, Current, Total
Unamortized market development fees.
Unamortized Market Development Fees
Unamortized Market Development Fees
Related Party Transactions [Abstract]
Shares Outstanding
Ending balance, shares
Beginning balance, shares
Accounts Receivable Net Current
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Accounts receivable, net
Accounts receivable, net
Lessee Operating Lease Renewal Term
Operating lease option to extend term
Natera Inc.
Natera Inc [Member]
Natera Inc.
Commission percentage of sale proceeds from common stock.
Commission Percentage Of Sale Proceeds From Common Stock
Commission percentage of sale proceeds from common stock
Commitments And Contingencies
Commitments and contingencies (Note 11)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Ending Balance, Weighted-Average Grant Date Fair Value
Beginning Balance, Weighted-Average Grant Date Fair Value
Operating Lease Liability
Present value of future minimum lease payments
Forecast [Member]
Scenario Forecast
Performance-based stock option.
Performance Based Stock Option [Member]
Performance-Based Stock Option
Performance-based stock options
Payment of costs related to Tempus And Merck Investment Agreements
Payment of costs related to tempus and merck investment agreements.
Payment of costs related to Tempus and Merck Investment Agreements
Concentration Risk By Benchmark [Axis]
Concentration Risk Benchmark
Short and Long Term Other Liabilities.
Short and Long Term Other Liabilities [Member]
Short- and long-term Other liabilities
Lessee Lease Description [Table]
Lessee Lease Description [Table]
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Effect of exchange rates on cash, cash equivalents and restricted cash
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Reconciliation of cash cash equivalents and restricted cash.
Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Profit Loss
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax
Reclassified accumulated foreign currency translation adjustment
Tempus investment agreement.
Tempus Investment Agreement
Longterm Debt Type [Domain]
Long-Term Debt, Type
Weighted Average Number Of Shares Outstanding Basic
Weighted-average shares outstanding, basic
Weighted-average common shares outstanding-basic
Weighted Average Number of Shares Outstanding, Basic, Total
Revenue from External Customers by Geographic Areas [Table Text Block]
Schedule of net revenues by geographic region
Scenario [Axis]
Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Property Plant And Equipment Type [Domain]
Long-Lived Tangible Asset
Inventory Raw Materials Net Of Reserves
Raw materials
Long Term Debt
Total carrying amount
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
Stockholders Equity
Ending balance
Beginning balance
Total stockholders’ equity
Preferred Stock Par Or Stated Value Per Share
Preferred stock, par value
Basis Of Accounting Policy Policy [Text Block]
Basis of Presentation
Lessee Operating Lease Existence Of Option To Extend
Operating lease, existence of option to extend
Statement Of Stockholders Equity [Abstract]
Assets, gross unrealized gains.
Assets Gross Unrealized Gains
Assets, Unrealized Gains
Share-Based Payment Arrangement, Tranche Two [Member]
Vesting in March 2028
Use of Estimates
Use Of Estimates
Fair Value Disclosures [Text Block]
Fair Value Measurements
First Warrant
First warrant.
First Warrant [Member]
UNITED STATES
United States
Gabor Bartha
Gabor Bartha [Member]
Gabor Bartha.
Tempus
Tempus.
Tempus [Member]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Segment Reporting, Other Segment Item, Amount
Other segment items
Plan Name [Domain]
Plan Name
Software and Software Development Costs [Member]
Software Loans
Interest Expense, Operating and Nonoperating
Interest expense
Interest Expense, Total
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]
Schedule of Amount of Transactions along with Amounts Due From and To Tempus
Condensed Financial Statements [Table Text Block]
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
Options vested and exercisable, Weighted-Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights
Share-based payment award, vesting rights
Related and Nonrelated Parties [Axis]
Accrued liabilities and other liabilities current.
Accrued Liabilities And Other Liabilities Current
Accrued and other current liabilities
Total accrued and other current liabilities
Entity Address, City or Town
Entity Address, City or Town
Derecognition of warrant liabilities due to exercise
Derecognition of warrant liabilities due to exercise
Derecognition of warrant liabilities due to exercise in full
Number Of Reportable Segments
Number of reportable segments
Security Exchange Name
Security Exchange Name
Agreement Reserve
Agreement reserve.
Agreement reserve
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Loss before income taxes
Concentration Risk Type [Domain]
Concentration Risk Type
Measurement Input Type [Domain]
Antidilutive Securities Name [Domain]
Antidilutive Securities, Name
Tranche three.
Tranche Three [Member]
February 2027
Two thousand nineteen equity incentive plan.
Two Thousand Nineteen Equity Incentive Plan [Member]
2019 Plan
Statistical Measurement
Range
Cost, Maintenance
Repairs and maintenance
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrant exercise price per share
Assets Current
Total current assets
Allocated Share Based Compensation Expense
Stock-based compensation expense
Document Period End Date
Document Period End Date
Fair Value Measurements Fair Value Hierarchy [Domain]
Fair Value Hierarchy and NAV
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax
Change during period
Significant accounting policies.
Significant Accounting Policies [Policy Text Block]
Significant Accounting Policies
Summary of shares of common stock available for issuance.
Summary Of Shares Of Common Stock Available For Issuance Table [Text Block]
Summary of Shares of Common Stock Reserved for Issuance
Inventory and other deferred costs.
Inventory And Other Deferred Costs [Abstract]
Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
Common stock shares purchased
Inventory and other deferred costs.
Inventory And Other Deferred Costs
Inventory and other deferred costs
Total inventory and other deferred costs
Operating Lease Liability Current Statement Of Financial Position Extensible List
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Statement of Financial Position [Abstract]
Restricted Stock Units R S U [Member]
Restricted Stock Units
Service-based RSUs
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Vesting [Axis]
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss), net of tax
Tempus Agreement
Tempus Agreement
Tempus Agreement
Contract with customer unsatisfied services
Contract with Customer Unsatisfied Services Revenue
Contract with customer unsatisfied services revenue.
Liabilities
Total liabilities
Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]
Financial Instruments
ModernaTX, Inc [Member]
ModernaTX, Inc.
ModernaTX, Inc.
Initial present value of debt.
Initial Present Value Of Debt
Initial present value of payment agreements
Finance Lease Commencement Month and Year
Finance lease commencement month and year.
Finance lease, commencement month and year
Lessee Operating Lease Liability Payments Due Year Two
2027
Assets, amortized cost basis.
Assets Amortized Cost Basis
Assets, Adjusted Cost
Weighted Average Number Of Diluted Shares Outstanding
Weighted-average shares outstanding, diluted
Weighted-average common shares outstanding-diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Securities Act File Number
Entity File Number
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
Change in unrealized gain on available-for-sale debt securities
Unrealized gain on available-for-sale debt securities
Cover [Abstract]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
Volatility, minimum
Measurement Input Type [Axis]
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total
Payable and accruals includes related party
Prepaid Expense And Other Assets Current
Prepaid expenses and other current assets
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
Unvested Restricted Stock Units, Number of Shares, forfeited
Loan, Securitized or Asset-Backed Financing Arrangement, Principal Outstanding
Software loans outstanding
Supplemental Balance Sheet Disclosures [Text Block]
Balance Sheet Details
Financial Instrument Subject to Mandatory Redemption, Average Exercise Price Per Share
Financial instrument subject to mandatory redemption, average exercise price per share.
Fair value determined at settlement as the fair value of average exercise price per share
Scenario [Domain]
U S Treasury Securities [Member]
U.S. Government Securities
Sale of Stock [Domain]
Segment Reporting Disclosure [Text Block]
Segment and Geographic Information
Leases
Lessee Operating Leases and Finance Leases [TextBlock]
Lessee operating leases and finance leases.
Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
Performance Based RSU Activity
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
Outstanding Options, Number of Shares, forfeited or expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total
Facility costs
Facility Cost
Facility cost.
Restructuring and other charges
Restructuring expenses recognized
Restructuring Charges
Restructuring Charges, Total
New Accounting Pronouncements Policy Policy [Text Block]
Recent Accounting Pronouncements
Lessee Operating Lease Liability Maturity Table [Text Block]
Schedule of Future Minimum Lease Payments
Revenue performance obligation unsatisfied service, period
Revenue Performance Obligation Unsatisfied Service, Period Description
Revenue performance obligation unsatisfied service, period description.
Schedule of inventory and other deferred costs.
Schedule Of Inventory And Other Deferred Costs Table [Text Block]
Schedule of Inventory and Other Deferred Costs
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Contract With Customer Liability Current
Contract liabilities
Short-term contract liabilities
Short-term contract liabilities
Short-term contract liabilities
Stock Issued During Period Shares Warrants Exercised
Stock issued during period shares warrants exercised.
Exercise of Tempus Warrants, Shares
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
Risk-free interest rate, minimum
Payment agreement with financing entity.
Payment Agreement With Financing Entity [Member]
Payment Agreement with Financing Entity
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
Unrecognized stock-based compensation cost of unvested
Lessee Operating Lease Term Of Contract
Lease term
Common Stock Shares Outstanding
Common stock, shares, outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Operating Lease Liability Current
Operating lease liabilities
Less: current portion of operating lease liability (included in accrued and other current liabilities)
Depreciation Depletion And Amortization
Depreciation and amortization
Depreciation and amortization expense
Depreciation, Depletion and Amortization, Total
Remaining performance obligation, amount
Revenue, Remaining Performance Obligation, Amount
Document Transition Report
Document Transition Report
Short Term Investments
Short-term investments
Short-Term Investments, Total
Amortization of premium (discount) on short-term investments.
Amortization Of Premium Discount On Short Term Investments
Amortization of discount on short-term investments
Research And Development Expense
Research and development
Research and Development Expense, Total
Cost of Revenue, Total
Cost Of Revenue
Cost of revenue
Lessee Operating Leases [Text Block]
Leases
Corporate headquarters and laboratory operations.
Corporate Headquarters And Laboratory Operations [Member]
Laboratory Operations and its New Corporate Headquarters
Statement Of Cash Flows [Abstract]
Stock Issued During Period Value New Issues
Proceeds from sales of common stock under, net
Assets Fair Value Disclosure [Abstract]
Assets
Moderna, Inc
Moderna, Inc [Member]
Moderna Inc
Two thousand nineteen equity incentive plan and two thousand twenty inducement plan.
Two Thousand Nineteen Equity Incentive Plan And Two Thousand Twenty Inducement Plan [Member]
2019 Plan and Inducement Plan
Earnings Per Share [Text Block]
Basic and Diluted Net Loss Per Common Share
Debt instrument imputed interest rate.
Debt Instrument Imputed Interest Rate
Imputed interest rate
Measurement Input, Expected Dividend Rate [Member]
Dividend Yield
Net loss
Net loss
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Outstanding Options, Aggregate Intrinsic Value
Donald Brown [Member]
Donald Brown.
Donald Brown
Options to purchase common stock.
Options To Purchase Common Stock [Member]
Options To Purchase Common Stock
Two thousand nineteen employee stock purchase plan.
Two Thousand Nineteen Employee Stock Purchase Plan [Member]
2019 Employee Stock Purchase Plan
Operating Lease Cost
Operating lease cost
Warrants and Rights Outstanding, Term
Expected term (in years)
Depreciation Depletion And Amortization Excluding Finance Lease Right of Use Asset
Depreciation and amortization expense
Depreciation depletion and amortization excluding finance lease right of use asset.
Increase (decrease) in inventories and other deferred costs.
Increase Decrease In Inventories And Other Deferred Costs
Inventory and other deferred costs
Dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Dividend yield
Operating Lease Payments
Cash paid for operating lease liabilities
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
Options vested and exercisable, Aggregate Intrinsic Value
Performance-based stock option activity, Fully vested and exercisable intrinsic value
Assets [Abstract]
Assets
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
Risk-free interest rate
Increase Decrease In Prepaid Deferred Expense And Other Assets
Prepaid expenses and other assets
Document Fiscal Year Focus
Document Fiscal Year Focus
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Change in fair value - recognized as non-cash gain within Other income (expense), net
Change in fair value-recognized as loss within Other income (expense), net in the consolidated statements of operations
Percentage of sales commission
Percentage of Sales Commission
Percentage of sales commission.
Remaining performance obligation, expected time of satisfaction
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Net Cash Provided By Used In Investing Activities [Abstract]
Cash flows from investing activities:
Accounts Payable Current
Accounts payable
Accounts Payable, Current, Total
Amount payable
Accrued liabilities and other liabilities disclosure current.
Accrued Liabilities And Other Liabilities Disclosure Current Table [Text Block]
Schedule of Accrued and Other Current Liabilities
Land Subject To Ground Leases
Area of office space
Research And Development Expense [Member]
Research and development
Stock issuance costs.
Stock Issuance Costs
Stock issuance cost
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
Schedule of Contract Assets and Liabilities
Transaction Type [Axis]
Transaction Type
Debt disclosure.
Debt Disclosure [Table]
Debt Disclosure [Table]
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Operating lease landlord agreed to contribution amount.
Operating Lease Landlord Agreed To Contribution Amount
Operating lease landlord agreed to contribution amount, approximate
Lessee Operating Lease Liability Payments Due Next Twelve Months
2026
Merck & co., Inc.
Merck Co Inc [Member]
Merck & Co., Inc.
Share-Based Payment Arrangement [Abstract]
Market Development Fees Received
Market development fees received.
Market development fees received
Accrued and Other Current Liabilities [Member]
Accrued and Other Current Liabilities.
Accrued and Other Current Liabilities
Assets Fair Value Disclosure
Assets, Fair Value
Assets, Fair Value Disclosure, Total
Sale of Stock [Axis]
Concentration Risk Percentage1
Concentration risk percentage
Revenue
Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block]
Summary of Restricted Stock Units Activity
Net Cash Provided By Used In Investing Activities
Net cash used in investing activities
Security12b Title
Title of 12(b) Security
Schedule of Segment Reporting Information, by Segment [Table]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, forfeited
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five
1 to 5 years
Money Market Funds [Member]
Money Market Funds
Related and Nonrelated Parties [Domain]
Exercise of Tempus Warrants
Stock issued during period value warrants exercised.
Stock Issued During Period Value Warrants Exercised
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
2025 (remaining three months)
Other Liabilities Noncurrent
Other long-term liabilities
Total other long-term liabilities
Debt Instrument Redemption Period [Domain]
Debt Instrument, Redemption, Period
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total
Finance lease ROU assets
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
1 to 5 years
Increase Decrease In Operating Capital [Abstract]
Changes in operating assets and liabilities
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Outstanding Options, Weighted-Average Exercise Price, Ending Balance
Outstanding Options, Weighted-Average Exercise Price, Beginning Balance
Performance-based stock option activity, exercise price
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total
Proceeds from issuance of common stock under equity incentive plans
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Clinical Diagnostic [Member]
Clinical diagnostic.
Clinical diagnostic
Additional Paid In Capital [Member]
Additional Paid-In Capital
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
Accrued and other current liabilities
Measurement Frequency
Fair Value Measurement Frequency [Domain]
Number of equal payments.
Number Of Equal Payments
Number of equal payments
Statement of Income Location, Balance [Axis]
Income Statement Location
Trading Symbol
Trading Symbol
Related Party Transaction [Table]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
Risk-free interest rate, maximum
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Less than 1 year
Employee Related Liabilities Current
Accrued compensation
Employee-related Liabilities, Current, Total
Net Cash Provided By Used In Financing Activities [Abstract]
Cash flows from financing activities:
Lessee, Finance Lease, Term of Contract
Finance lease term
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Expected term (in years)
Fair Value Measurements Recurring
Fair Value Measurements Recurring [Member]
Lessee Operating Lease Liability Payments Due
Total future minimum lease payments
Statement Equity Components [Axis]
Equity Components
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
Options vested and exercisable, Weighted-Average Remaining Contractual Term (in years)
Equity Component [Domain]
Equity Component
Schedule Of Share Based Compensation Activity Table [Text Block]
Summary of Stock Option Activity
Fair Value By Asset Class [Axis]
Asset Class
At-the-market facility.
At-The-Market Facility [Member]
ATM facility
Stephane Mouradian
Stephane Mouradian [Member]
Stephane Mouradian.
Restricted stock units vested, shares
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total
Deepshikha Bhandari [Member]
Deepshikha Bhandari.
Deepshikha Bhandari
Proceeds from ESPP, shares
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Major Customers [Axis]
Customer
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]
Proceeds from sale of common stock under Tempus Investment Agreement
Proceeds from sale of common stock under Tempus Investment Agreement
Proceeds from sale of common stock under Tempus Investment Agreement
Depreciation, Depletion and Amortization, Nonproduction
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation and amortization
Statement of Comprehensive Income [Abstract]
Statement of Comprehensive Income [Abstract]
Maximum [Member]
Maximum
Enterprise Sales
Enterprise Sales [Member]
Enterprise sales.
Range [Axis]
Statistical Measurement
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Outstanding Options, Weighted-Average Exercise Price, exercised
Contract with Customer, Liability, Noncurrent
Long-term contract liabilities (included in other long-term liabilities)
Long-term contract liabilities (included in other long-term liabilities)
Long-term contract liabilities (included in other long-term liabilities)
Receivable
Receivables, Net, Current
Receivables, Net, Current, Total
Amortized Costs and Fair Value of Marketable Debt Securities [Table Text Block]
Amortized Costs and Fair Value of Marketable Debt Securities.
Amortized Costs and Fair Value of Marketable Debt Securities by Contractual Maturity
Market Development Fees received from Tempus (Note 8)
Market Development Fees received from Tempus
Market Development Fees received from Tempus
Warrants and Rights Outstanding
Warrants and rights outstanding
Related Party Transaction, Amounts of Transaction
Invoice amount
Debt Disclosure [Line Items]
Debt disclosure.
Debt Disclosure [Line Items]
Outstanding stock awards
Shares subject to options and restricted Stock or Rsu awards.
Shares Subject To Options And Restricted Stock Or R S U Awards
Outstanding stock options and awards (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Volatility
Preferred Stock Shares Authorized
Preferred stock, shares authorized
Employee stock purchase plan.
Employee Stock Purchase Plan [Member]
ESPP
Costs And Expenses
Total costs and expenses
Lessee, Finance Lease, Description
Finance lease description
Schedule Of Debt Table [Text Block]
Schedule of Amounts Outstanding
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Related Party Transaction [Line Items]
Total
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
Revenue From Contract With Customer [Text Block]
Revenue
Entity Registrant Name
Entity Registrant Name
Debt Disclosure [Text Block]
Loans
Debt Instrument Periodic Payment Principal
Payment of debt
Other Deferred Costs Net
Other deferred costs
Other Deferred Costs, Net, Total
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
Investments, Unrealized Losses
Customer Concentration Risk [Member]
Customer
Customer Concentration Risk
Other
Other [Member]
Other.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Other Nonoperating Income Expense
Other income (expense), net
Other Nonoperating Income (Expense), Total
Other Expense
Income Tax Expense Benefit
Provision for income taxes
Income Tax Expense (Benefit), Total
Fair Value By Measurement Frequency [Axis]
Measurement Frequency
Proceeds from Issuance of Common Stock
Proceeds from sale of stock
Proceeds from sales of common stock under ATM facility, net of commissions
Costs And Expenses [Abstract]
Costs and expenses
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock Based Compensation Arrangement By Share Based Payment Award [Line Items]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Schedule of Risk-free Interest Rate Based on U.S. Treasury Yield Curve Over Expected Term of Warrants
Entity Common Stock Shares Outstanding
Entity Common Stock, Shares Outstanding
Liability Class [Axis]
Accumulated Other Comprehensive Income Loss Net Of Tax
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated other comprehensive income (loss)
Payments To Acquire Property Plant And Equipment
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment, Total
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Unvested Restricted Stock Units, Number of Shares, granted
PSUs granted, Number of Shares
Assets
Total assets
Income Statement [Abstract]
Selling General And Administrative Expenses [Member]
Selling, general, and administrative
Christian Haudenschild [Member]
Christian Haudenschild.
Christian Haudenschild
Tranche one.
Tranche One [Member]
February 2025
Number of shares issued
Stock Issued During Period Shares New Issues
Proceeds from sales of common stock, net, shares
Lease Cost [Abstract]
Lease cost
Performance Based RSU Activity [Member]
Performance based RSU activity.
Performance Based RSU Activity
Proceeds from Fees Received
Market Development Fees
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Unvested Restricted Stock Units, Number of Shares, vested
Earnings Per Share Diluted
Net loss per share, diluted
Net loss per common share-diluted
Earnings Per Share, Diluted, Total
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of reported segment revenue, segment loss and significant segment expenses
Disaggregation of Revenue [Abstract]
City Area Code
City Area Code
Repayments of loans
Repayments Of Payment Agreements With Financing Entity
Repayments of payment agreements with financing entity.
Lease expiration year.
Lease Expiration Year
Lease Expiration Year
Debt Instrument Face Amount
Principal amount
Principal
Concentration of credit risk and other risks and uncertainties policy.
Concentration Of Credit Risk And Other Risks And Uncertainties Policy Policy [Text Block]
Concentration of Credit Risk and Other Risks and Uncertainties
Variable Lease Cost
Variable lease cost
Gain (Loss) from Litigation Settlement
Gain (Loss) from Litigation Settlement, Total
Gain on settlement recognized
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
Restricted Stock Units, Aggregate Fair Value, vested
Proceeds from ESPP
Stock Issued During Period, Value, Employee Stock Purchase Plan
Pfizer Inc.
Pfizer Inc [Member]
Pfizer Inc.
Operating Lease Weighted Average Remaining Lease Term1
Operating leases, weighted-average remaining lease term
Segment Reporting Information [Line Items]
Lease Cost
Total lease cost
Assets, gross unrealized losses.
Assets Gross Unrealized Losses
Assets, Unrealized Losses
Property Plant And Equipment Net
Property and equipment, net
Property, Plant and Equipment, Net, Total
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Right-of-use finance lease assets obtained in exchange for finance lease liabilities
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
Options vested and exercisable, Number of Shares
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Cash, cash equivalents and restricted cash, end of period
Total cash, cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Cash, cash equivalents and restricted cash, beginning of period
Operating Income Loss
Loss from operations
Retained Earnings [Member]
Accumulated Deficit
Transaction [Domain]
Transaction
Share Based Compensation
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense, Total
Measurement Input, Price Volatility [Member]
Volatility
Pharma Tests and Services
Pharma Tests and Services [Member]
Pharma tests and services.
Lab Supplies and Outside Services
Lab supplies and outside services.
Lab supplies and outside services
Operating Lease Weighted Average Discount Rate Percent
Operating leases, weighted-average discount rate
Operating Lease Liability Noncurrent
Long-term operating lease liabilities
Long-term operating lease liabilities
Fair Value Inputs Level1 [Member]
Level 1
Net Cash Provided By Used In Financing Activities
Net cash provided by financing activities
Lease Cost Table [Text Block]
Components of Lease Costs
Non Us [Member]
Others
Percentage of total revenue
Percentage of Revenue
Percentage of revenue.
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Schedule of Potentially Dilutive Shares Excluded from Computation of Diluted Net Loss per Common Share
Corporate Debt Securities [Member]
Corporate Debt Securities
Entity Interactive Data Current
Entity Interactive Data Current
Contract liabilities
Increase Decrease In Contract With Customer Liability
Statement of Income Location, Balance [Domain]
Income Statement Location
Net Cash Provided By Used In Operating Activities [Abstract]
Cash flows from operating activities:
Increase (Decrease) in Other Noncurrent Liabilities
Other long-term liabilities
Schedule of Percentage of Revenue and Accounts Receivable from Customers
Schedules Of Concentration Of Risk By Risk Factor [Text Block]
Entity Tax Identification Number
Entity Tax Identification Number
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Impact of Changes in Fair Value of Shares on Number of Shares
Fair value determined at settlement as the fair value of shares delivered
Share Price
Share price
Longterm Debt Type [Axis]
Long-Term Debt, Type
Investment Agreement
Investment Agreement.
Investment Agreement [Member]
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
Proceeds from maturities of available-for-sale debt securities
Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]
Company and Nature of Business
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]
Changes in foreign currency translation adjustments:
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals [Member]
Regeneron Pharmaceuticals.
Local Phone Number
Local Phone Number
Other Liabilities, Current
Other current liabilities
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Unrecognized stock-based compensation cost of unvested options
Short-term lease cost
Short Term Lease Cost
Cash and cash equivalents, gross unrealized losses.
Cash And Cash Equivalents Gross Unrealized Losses
Cash and cash equivalents, Unrealized Losses
Merck Sharp and Dohme LLC [Member]
Merck Sharp and Dohme LLC.
Merck Sharp and Dohme LLC [Member]
Accounting Policies [Abstract]
Disaggregation Of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Revenue From Contract With Customer Excluding Assessed Tax
Revenue
Restricted Cash And Investments Noncurrent
Restricted cash, included in other long-term assets
Restricted Cash and Investments, Noncurrent, Total
Lessee Operating Lease Liability Payments Due Year Four
2029
Commercial Paper [Member]
Commercial Paper
Reserved for future award grants
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
Reserved for future option and award grants (in shares)
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Unrecognized stock-based compensation of unvested options, recognized over weighted-average period
Percentage of common stock owned
Percentage of common stock owned.
Percentage of Common Stock Owned
Entity Emerging Growth Company
Entity Emerging Growth Company